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Abstract : Galanin has been known as a biological active neuropeptide originally isolated from
porcine intestine, and it has been known to be involved in various physiological and behavioral
actions.  As for the gastrointestinal functions galanin inhibits gastric acid secretion.  The
present study was aimed to examine the distribution of c-Fos protein in the brain after
intraperitoneal injection of galanin in Wistar rats.  In the test experiments, one and a half hours
after the intraperitoneal injection of galanin, rats were perfused transcardially with saline
solution and fixed with fixatives.  Then brains were removed and sectioned at 40 μm in
thickness.  Every fourth section was treated with polyclonal anti-c-Fos antiserum, and c-Fos
protein was immunohistochemically stained using the avidin-biotin complex method.  In the
control experiments saline solution was intraperitoneally injected, and brains were removed
and processed similarly as described above.  Intraperitoneal injection of galanin induced much
more c-Fos-immunoreactive (c-Fos-ir) neurons in the area postrema (AP) in the test experiment
than in the control experiment.  The present results suggest that galanin may have central
actions through the AP neurons in playing roles in the gastroenteric functions.
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INTRODUCTION
Galanin is a 29-amino acid residue neuropeptide,
originally isolated from porcine intestine in 1983 by
Tatemoto and coworkers1).  Galanin has been known
as a biological active peptide that shows many
physiological and behavioral actions such as learning
and memory, epileptic activity, nociception, spinal
reflexes and feeding2,3,4,5).  It was reported that
galanin increased food intake after its central
injection, and the activity of galanin was found to be
induced via its binding to galanin receptor in the rat
hypothalamus6).  Recently, it was reported that the
intracerebroventricular injection of galanin induced c-
fos in hypothalamus as well as some other brain
regions7).  On the other hands the physiological
actions of peripheral administered galanin were also
reported including the contraction of smooth muscle8),
activation of an ATP-dependent potassium channel9),
and inhibition of glucose-stimulated insulin release10).
It was also reported that galanin decreased secretion
of gastric acid11,12).  However, whether the effects of
peripheral administration of galanin were due to be
via the central neurons has not been clarified.  Thus in
this study it was examined whether the peripheral
28
administration of galanin may induce c-Fos protein in
the brain.  c-Fos expression method presented
evidence that proto-oncogene c-fos expresses c-Fos
protein rapidly and transiently within neurons in
response to synaptic activation13,14,15).  That is, the
expression of c-Fos protein in neurons indicated the
excitation of neurons in response to synaptic
activation after some stimulations.  In the present
study we undertook to identify the neuronal
expression of c-Fos protein throughout the CNS that
might be produced after intraperitoneal
administration of galanin.  We found that c-Fos
protein was expressed in many neurons in several
nuclei throughout the brain.
MATERIALS AND METHODS
We undertook to examine which neurons in the
CNS may express c-Fos protein after intraperioneal
injection of galanin.  In the test experiments male
Wistar rats weighing 230-250 g (n=4) were
intraperitoneally injected with galanin (250 μg/kg) in
250 μl of 0.9% NaCl solution.  One and a half hours
after the injection of galanin, rats were anesthetized
with pentobaribital sodium (intraperitoneally,
50mg/kg), and perfused via the left ventricle with
about 20 ml of saline to flush out the blood.  This was
immediately followed by 100 ml of 0.5%
glutaraldehyde and 4% paraformaldehyde (PFA,
Merck, German) in 0.1 M phosphate buffer (PB, pH
7.4), and 400 ml of 4% PFA in PB.  The brains were
removed and cut into two blocks at the level between
superior and inferior colliculus.  They were fixed in
4% PFA in PB for further 1.5 h at 4℃, then soaked
stepwise in 10, 20, 25% sucrose in PB at 4℃.  The
brains were frozen and cut into serial transverse
sections at 40 μm in thickness.  The sections were
collected in plates containing PB chilled by ice water.
One group of every fourth section was rinsed in 0.1 M
Tris-saline (TS, pH 7.4) three times, incubated with
0.5% bovine serum albumin (BSA) in TS for 20 min and
incubated with sheep anti-c-Fos polyclonal antiserum
(1:100; sc-52, Santa Cruz Biotech.  Inc., USA) in 0.5%
BSA at 4℃ for 16 h.  Afterwards, the sections were
rinsed three times in TS, and then incubated in avidin
and biotin solution respectively for 15 min.
Thereafter they were incubated for 20 min with 2%
normal rabbit serum in TS to block nonspecific
bindings, and incubated for 60 min with anti-sheep
IgG in TS.  After rinsed three times in TS, the
sections were incubated for 60 min in Vectastatin
ABC kit (Vector Lab., Burlingame, CA, USA), and then
treated with diaminobenzidine-nickel solution
containing 0.003% H2O2.  After that, the sections were
rinsed in TS twice and rinsed further in PB.  They
were mounted on glass slides and dried at room
temperature.  The sections on the slides were
dehydrated in a graded ethanol series (50%, 70% 95%,
99%), infiltrated with xylene and coverslipped in
Permount (Fisher Comp., USA).  Control rats (n=4)
were sham-operated and injected with 250 μl of 0.9%
NaCl solution.  Brain sections were similarly
processed as above.  c-Fos protein localized in
neuronal nuclei was visualized as black precipitates of
nickel-intensified diaminobenzidine reaction products.
c-Fos-immunoreactive (c-Fos-ir) neurons were
surveyed under bright-field microscopy.  Brain
histology was checked against the rat brain atlas of
Swanson16).  Mann-Whitney U-tests were performed
to compare the data between the two groups. 
RESULTS AND DISCUSSION
Intraperitoneal injection of galanin (250 μg/kg)
induced c-Fos protein in central nuclei and
circumventricular organs.  Fig.1 shows c-Fos-ir
neurons found in the area postrema (AP).  Fig.2 and
Fig.3 show histograms of c-Fos-ir neurons in the
nuclei and the cirucmventricular organs in the brain.
The c-Fos-ir neurons induced in each nuclei were
averaged per one brain section.  Increases in the
number of c-Fos-ir neuronal profiles, compared to that
in control experiment, were observed in nuclei and
circumventricular organs from the medulla oblongata
to the basal telencephalon after intraperitoneally
Fig. 1. The photomicrograhs of c-Fos-immunreactivity in the
area postrema (a). c-Fos-ir neurons were stained as
black dots indicated by arrows in the enlarged
microphotograph (b). Scale bars: 0.5mm.
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injection of galanin.  The site in which significantly
much more neurons expressed c-Fos protein in the
test experiments than in the control experiments was
the AP (38±14 c-Fos-ir neurons in the test, 12±2
number of c-Fos-ir neurons in the control, 8±3 c-Fos-
ir neurons.  c-Fos protein was also detected in many
other nuclei such as the dorsal motor nucleus of the
vagus nerve (DMX), solitary tract nucleus (NTS),
ventromedial hypothalamic nucleus (VLM), locus
coeruleus nucleus (LC), lateral parabrachial nucleus
(Pbl), paraventricular nucleus thalamus (PVT), arcuate
nucleus hypothalamus (ARH), dorsal medial thalamus
nucleus (DMH), central nucleus amygdala (CEA),
posterior hypothalamic nucleus (PVP), anterior
hypothalamic nucleus (AHP), supraoptic nucleus (SO),
retrochiasmatic area (RCh), subfornical organ (SFO).
However, in these central nuclei or the
circumventricular organs no significant differences in
the c-Fos-ir neurons between the test and control
experiments were observed.
It is to be considered that the diffusion of galanin
into the brain is limited by the blood-brain barrier
(BBB) mechanism.  However, the BBB is lacking in
the circumventricular organs so that peptides or
peptide fragments might possibly penetrate into the
brain17).  Thus, galanin may possibly penetrate the
brain.  That is why we tried peripheral injection of
galanin to observe the expression of c-Fos protein in
central neurons.  In this study intraperitoneal
injection of galanin induced expression of c-Fos
protein in many neurons in the AP.  The AP is known
to be one of the circumventricular organs which lie
outside the blood-brain barrier.  The AP/NTS, the Pbl,
the CEA and the PVH are brain sites that contain
galanin-immunoreactive cell bodies and
terminals1,18,19,20,21).  These brain regions are involved
in the regulation of feeding, and injection of galanin
into the AP/NTS and above-mentioned brain regions
stimulate food intake22).  As described above AP is
known to be lack in the blood brain barrier and galanin
might stimulate directly the galanin receptors, though
the type of the galanin receptor has to be identified
out of three receptors GalR1, GalR2, GalR3 and
receptor subtypes, gal1, gal2 and gal323,24,25,26).
According to the results by Mariann et al, galanin
might stimulate neurons in the AP/NTS via galanin
receptors27,28,29).  Koegler and Ritter reported that
galanin injection into the AP/NTS stimulate feeding
in rats, and suggested that galanin receptors in the
AP/NTS region mediate feeding in response to
galanin and that the galaninergic nerve terminals
innervating these receptors may originate in part
from cell bodies in the PVH22).  It is conceivable that
intraperitoneal injection of galanin induced expression
of c-Fos protein in not so many neurons in the central
nuclei, because galanin usually causes inhibitory
effect rather than stimulatory effect on various
physiological functions11,12,17,18,26,27,30,31).  It is also
conceivable that it mighy be difficult for galanin to
Fig. 3. Histgrams of numbers of c-Fos-immunoreactive
neurons in nuclei above the brain stem after
intraperitonial injection of galanin (solid column: 250 μ
g/kg in 250 μl saline) or saline (open column: 250 μl
saline). *P<0.05 compared between two groups.
Fig. 2. Histgrams of numbers of c-Fos-immunoreactive
neurons in nuclei of the brain stem after intraperitonial
injection of galanin (solid column: 250 μg/kg in 250μl
saline) or saline (open column: 250 μl saline). *P<0.05
compared between two groups.
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stimulate central neurons directly.  In this study, it
was clarified that galanin may stimulate central
neurons via the neurons in the AP, suggesting playing
some physiological functions through the central
nervous system.
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